Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4184
+0.0312 (8.06%)
At close: Nov 13, 2026, 4:00 PM EST
0.4252
+0.0068 (1.63%)
After-hours: Nov 13, 2026, 7:47 PM EST

Ensysce Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6.195.075.212.232.523.53
Revenue Growth
37.91%-2.75%133.58%-11.61%-28.54%-10.17%
Cost of Revenue
10.3810.387.227.5919.844.69
Gross Profit
-4.19-5.31-2.01-5.36-17.31-1.16
Selling, General & Admin
5.094.934.725.366.9118.71
Operating Expenses
7.324.934.725.366.9118.71
Operating Income
-11.51-10.24-6.73-10.72-24.22-19.87
Interest Expense
-0.01-0.02-1.29-0.35-1.25-3.22
Other Non Operating Income (Expenses)
-0.10.080.030.3-0.53-2.91
EBT Excluding Unusual Items
-11.31-10.18-7.99-10.77-26-26
Other Unusual Items
---0.151.79-3.15
Pretax Income
-91.21-10.18-7.99-10.63-24.21-29.15
Earnings From Continuing Operations
-91.21-10.18-7.99-10.63-24.21-29.15
Minority Interest in Earnings
0000.010.040.06
Net Income
-91.21-10.18-7.99-10.61-24.17-29.08
Preferred Dividends & Other Adjustments
--00.010.910.8
Net Income to Common
-91.21-10.18-7.99-10.63-25.09-29.89
Net Income Growth
------
Shares Outstanding (Basic)
103100-
Shares Outstanding (Diluted)
103100-
Shares Change
441.64%266.55%362.24%1158.33%--
EPS (Basic)
-8.70-3.98-11.45-70.40-2091.33-
EPS (Diluted)
-8.71-3.98-11.45-70.40-2091.33-
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-8.44-7.93-7.5-10.78-17.89-8.24
Free Cash Flow Per Share
-0.81-3.10-10.75-71.42-1491.24-
Gross Margin
-67.66%-104.81%-38.57%-240.17%--32.82%
Operating Margin
-185.96%-202.13%-129.18%-480.52%-959.91%-562.71%
Profit Margin
-1473.72%-200.84%-153.31%-476.39%-994.12%-846.37%
Free Cash Flow Margin
-136.33%-156.51%-144.00%-483.30%-708.87%-233.41%
EBITDA
--10.23---24.22-19.87
EBITDA Margin
--202.00%----
D&A For EBITDA
-0.01--00
EBIT
-11.51-10.24-6.73-10.72-24.22-19.87
EBIT Margin
-185.96%-202.12%-129.18%---
SEC Filings: 10-K · 10-Q